Top
Call Now Open an account
Open an account
19.25725746 73.13076782

Open a Demat Account and Start Trading!

  • +91

Timeline

1 The increasing dependency on tech due to the pandemic is resulting in better performance of IT stocks

1) The increasing dependency on tech due to the pandemic is resulting in better performance of IT stocks. The positive result of Accenture also resulted in fresh buying of tech stocks in Indian market. 2) Vodafone has won arbitration against India over the government's retro tax demand of Rs 20,000 crore at the Permanent Court of Arbitration in Hague on Friday. The Hague Court in its ruling said that the conduct of the Indian tax department is in breach of "fair and equitable" treatment. The Arbitration Tribunal has directed the Indian Tax Department to cease the conduct on the question. A failure to comply will engage its international responsibility. #MOMarketUpdates #MotilalOswal #Vodafone #ITstocks #Indianstockmarket #stockrecommendation #investingtips #NSE #BSE

Posted on : 25 Sep 2020 6:02 PM
As the world highly depends on technology during Covid 19, the technology stocks the IT stocks are gaining attention

As the world highly depends on technology during Covid-19, the technology stocks the IT stocks are gaining attention. HCL has hit a 52-week new high. #MOMarketUpdates #MotilalOswal #ITstocks #indianstockmarket #stockrecommendation #HCL #TCS

Posted on : 22 Sep 2020 5:09 PM
The Pharma stocks are positive due to multiple approvals of US FDA for different medicines

The Pharma stocks are positive due to multiple approvals of US FDA for different medicines. The companies are also manufacturing the drugs for the primary treatment of Covid-19. Dr Reddy's Laboratories reclaimed the tag of being the second most valuable listed pharmaceutical company. Sun Pharma is the most valued listed company of India with the market cap of Rs 1.26lakh cr. With a favourable ruling in the appeals court, the odds of launching gVascepa also rise considerably. Bristol Myers Squibb had inked a patent settlement with Dr. Reddy’s Laboratories, allowing the Indian generics company to start with a “volume-limited” launch sometime after March 2022. The exact date of the rollout, and amount of generic Revlimid Dr. Reddy’s will be allowed to sell, are confidential. But on January 31, 2026, the company will have a license to sell its generic Revlimid with no limits. #MOMarketUpdates #IndianStockMarket #MotilalOswal #NiftyPharma #NSE #BSE #Recommendation #Stocktip #Stockrecommendation

Posted on : 18 Sep 2020 5:44 PM

Categories

  • Stock Broker
  • Financial Consultant
  • Financial Planner
  • Online Share Trading Centre
  • Brokers & Investment Firm

Tags

  • Motilal Oswal
  • Motilal Oswal Near me
  • Motilal Oswal mutual fund office near me
  • Best Stock broker near me
  • Mutual funds
  • IPO investment
  • Equity trading
  • Online share trading
  • BSE sensex
  • Portfolio management services
  • Investment bonds
  • Best SIP plans
  • Best mutual funds for SIP
  • Commodity market
  • Currency market
  • Open demat account
  • Online trading account
  • Open trading account
  • Investment bonds
  • Financial advisory services
  • Stock broker in Kalyan
  • Best Portfolio managements services in Kalyan
{"77395":"http:\/\/stockbroker.motilaloswal.com\/motilal-oswal-financial-services-limited-sagar-b-aher-stock-broker-kalyan-thane-45973\/TimelineDetails\/77395","77402":"http:\/\/stockbroker.motilaloswal.com\/motilal-oswal-financial-services-limited-sagar-b-aher-stock-broker-kalyan-thane-45973\/TimelineDetails\/77402","77408":"http:\/\/stockbroker.motilaloswal.com\/motilal-oswal-financial-services-limited-sagar-b-aher-stock-broker-kalyan-thane-45973\/TimelineDetails\/77408"}